Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van Olphen, Sophie H.
47  Ergebnisse:
Personensuche X
?
1

Use of immunohistochemical biomarkers as independent predic..:

Janmaat, Vincent T. ; van Olphen, Sophie H. ; Biermann, Katharina E....
PLOS ONE.  12 (2017)  10 - p. e0186305 , 2017
Link: https://doi.org/10.1371/..
 
?
2

Neoplastic Progression in Patients with Short Segment Barre..:

Vennelaganti, Sreekar ; Parasa, Sravanthi ; Vennalaganti, Prashanth...
Gastroenterology.  152 (2017)  5 - p. S456 , 2017
Link: https://doi.org/10.1016/..
 
?
3

Sa1250 Improved Prediction of Neoplastic Progression in Pat..:

Ten Kate, Fiebo ; Nieboer, Daan ; van Olphen, Sophie H....
Gastroenterology.  150 (2016)  4 - p. S256-S257 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Sa1926 SOX2 and p53 Protein Expression Predicts Response to..:

van Olphen, Sophie H. ; Biermann, Katharina ; wijnhoven, bas P....
Gastroenterology.  148 (2015)  4 - p. S-357 , 2015
Link: https://doi.org/10.1016/..
 
?
5

706 SOX2 As a Novel Marker to Predict Neoplastic Progressio..:

Van Olphen, Sophie H. ; Biermann, Katharina ; Kastelein, Florine...
Gastroenterology.  146 (2014)  5 - p. S-122 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Sa1855 Cost-Effectiveness of Barrett's Esophagus Surveillan..:

Van Olphen, Sophie H. ; Kastelein, Florine ; Steyerberg, Ewout W....
Gastroenterology.  146 (2014)  5 - p. S-313 , 2014
Link: https://doi.org/10.1016/..
 
?
7

Lower Annual Rate of Progression of Short-Segment vs Long-S..:

Hamade, Nour ; Vennelaganti, Sreekar ; Parasa, Sravanthi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050470/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

Loss of SRY-box2 (SOX2) expression and its impact on surviv..:

ten Kate, F.J.C. (F. J.C.) ; Olphen, S.H. (Sophie) van ; Bruno, M.J. (Marco)...
http://repub.eur.nl/pub/106572.  , 2017
Link: http://repub.eur.nl/pub/..
 
?
9

Use of immunohistochemical biomarkers as independent predic..:

Janmaat, V.T. (Vincent) ; Olphen, S.H. (Sophie) van ; Biermann, K. (Katharina)...
http://repub.eur.nl/pub/102589.  , 2017
Link: http://repub.eur.nl/pub/..
 
?
10

Advances in Barrett's Esophagus Surveillance and Improved P..:

Olphen, S.H. (Sophie) van
http://repub.eur.nl/pub/99451.  , 2017
Link: http://repub.eur.nl/pub/..
 
?
11

Value of cyclin A immunohistochemistry for cancer risk stra..:

Olphen, S.H. (Sophie) van ; Ten Kate, F.J.C. (Fiebo J.C.) ; Doukas, M. (Michael)...
http://repub.eur.nl/pub/96534.  , 2016
Link: http://repub.eur.nl/pub/..
 
?
12

Use of immunohistochemical biomarkers as independent predic..:

Vincent T Janmaat ; Sophie H van Olphen ; Katharina E Biermann...
http://europepmc.org/articles/PMC5653304?pdf=render.  , 2017
Link: https://doi.org/10.1371/..
 
?
13

Loss of SRY-box2 (SOX2) expression and its impact on surviv..:

ten Kate, F J C ; van Olphen, S H ; Bruno, M J...
British Journal of Surgery.  104 (2017)  10 - p. 1327-1337 , 2017
Link: https://doi.org/10.1002/..
 
?
14

Mo1861 Survival of Patients With Barrett-Related Adenocarci..:

Kastelein, Florine ; Spaander, Manon C. ; van Olphen, Sophie...
Gastroenterology.  144 (2013)  5 - p. S-677 , 2013
Link: https://doi.org/10.1016/..
 
?
15

Sa1987 AMACR Immunohistochemistry for Prediction of Neoplas..:

Kastelein, Florine ; Biermann, Katharina ; van Olphen, Sophie...
Gastroenterology.  144 (2013)  5 - p. S-352 , 2013
Link: https://doi.org/10.1016/..
 
1-15